Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
128.43
+0.04 (0.03%)
At close: Aug 6, 2025, 4:00 PM
130.39
+1.96 (1.53%)
After-hours: Aug 6, 2025, 4:37 PM EDT
New Relic Stock Forecast
Stock Price Forecast
The 22 analysts that cover New Relic stock have a consensus rating of "Strong Buy" and an average price target of $165.59, which forecasts a 28.93% increase in the stock price over the next year. The lowest target is $115 and the highest is $219.
Price Target: $165.59 (+28.93%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for New Relic stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 7 | 7 | 7 | 10 | 10 |
| Buy | 11 | 11 | 11 | 11 | 9 | 9 |
| Hold | 4 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 20 | 20 | 20 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $165 → $175 | Strong Buy | Maintains | $165 → $175 | +36.26% | Aug 1, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $140 → $145 | Hold | Maintains | $140 → $145 | +12.90% | Jul 31, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $146 → $144 | Buy | Maintains | $146 → $144 | +12.12% | Jul 31, 2025 |
| Stifel | Stifel | Strong Buy Maintains $166 → $174 | Strong Buy | Maintains | $166 → $174 | +35.48% | Jul 31, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $150 → $158 | Buy | Maintains | $150 → $158 | +23.02% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
2.74B
from 2.36B
Increased by 16.12%
Revenue Next Year
3.15B
from 2.74B
Increased by 15.06%
EPS This Year
3.99
from 3.29
Increased by 21.15%
EPS Next Year
6.18
from 3.99
Increased by 55.14%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.0B | 3.5B | 4.0B | ||
| Avg | 2.7B | 3.1B | 3.5B | ||
| Low | 2.5B | 2.8B | 3.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.3% | 28.0% | 26.8% | ||
| Avg | 16.1% | 15.1% | 12.0% | ||
| Low | 8.2% | 0.9% | -3.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.92 | 7.94 | 12.01 | ||
| Avg | 3.99 | 6.18 | 8.31 | ||
| Low | 2.88 | 4.03 | 3.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 49.7% | 99.1% | 94.2% | ||
| Avg | 21.2% | 55.1% | 34.4% | ||
| Low | -12.4% | 1.0% | -42.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.